{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:03:35Z","timestamp":1769821415424,"version":"3.49.0"},"reference-count":10,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1684\/ejd.2018.3431","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:20:29Z","timestamp":1696864829000},"page":"88-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Infliximab-induced bullous pemphigoid and anti-desmoglein 3 and anti-BP180 autoantibodies in a patient with ulcerative colitis"],"prefix":"10.1684","volume":"29","author":[{"given":"Naomi","family":"Tani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"3431_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000243805","volume":"219","author":"M Bordignon","year":"2009","unstructured":"Bordignon M, Belloni-Fortina A, Pigozzi B, Tarantello M, Alaibac M. Bullous pemphigoid during long-term TNF-\u03b1 blocker therapy. Dermatology 2009; 219:357\u20138.","journal-title":"Dermatology"},{"key":"3431_CR2","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1111\/j.1365-2230.2008.03204.x","volume":"34","author":"B Stausb\u00f8l-Gr\u00f8n","year":"2009","unstructured":"Stausb\u00f8l-Gr\u00f8n B, Deleuran M, Sommer Hansen E, Kragballe K. Development of bullous pemphigoid during treatment of psoriasis with adalimumab. Clin Exp Dermatol 2009; 34: e285\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"3431_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1365-2230.2011.04102.x","volume":"36","author":"J Kluk","year":"2011","unstructured":"Kluk J, Goulding JM, Bhat J, Finch TM. Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept. Clin Exp Dermatol 2011; 36: 871\u20133.","journal-title":"Clin Exp Dermatol"},{"key":"3431_CR4","doi-asserted-by":"publisher","first-page":"15734","DOI":"10.1007\/s00384-014-1924-9","volume":"29","author":"M Ricci","year":"2014","unstructured":"Ricci M, Zauli S, Zelante A, Trevisani L, Virgili A, Bettoli V. Bullous pemphigoid occurring under anti-tumor necrosis factor-\u03b1 therapy. Int J Colorectal Dis 2014; 29: 15734.","journal-title":"Int J Colorectal Dis"},{"key":"3431_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdcr.2015.12.006","volume":"2","author":"EN Wilmer","year":"2016","unstructured":"Wilmer EN, Becker N, Chen A, Kroumpouzos G. Etanercept-induced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient. JAAD Case Rep 2016; 2: 25\u20137.","journal-title":"JAAD Case Rep"},{"key":"3431_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000318008","volume":"221","author":"L Boussemart","year":"2010","unstructured":"Boussemart L, Jacobelli S, Batteux F, et al. Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports. Dermatology 2010; 221: 201\u20135.","journal-title":"Dermatology"},{"key":"3431_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","volume":"25","author":"R Perez-Alvarez","year":"2013","unstructured":"Perez-Alvarez R, P\u00e9rez-de-Lis M, Ramos-Casals M, & BIOGEAS study group. Biologics-induced autoimmune diseases. Curr Opin Rheumatol 2013; 25:56\u201364.","journal-title":"Curr Opin Rheumatol"},{"key":"3431_CR8","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1016\/j.febslet.2011.04.025","volume":"585","author":"X Chen","year":"2011","unstructured":"Chen X, Oppenheim JJ. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett 2011; 585:3611\u20138.","journal-title":"FEBS Lett"},{"key":"3431_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-015-3140-6","volume":"35","author":"JL Vaz","year":"2016","unstructured":"Vaz JL, Fernandes V, Nogueira F, Arn\u00f3bio A, Levy RA. Infliximab-induced autoantibodies: a multicenter study. Clin Rheumatol 2016; 35:325\u201332.","journal-title":"Clin Rheumatol"},{"key":"3431_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/ced.12114","volume":"38","author":"H Reddy","year":"2013","unstructured":"Reddy H, Shipman AR, Wojnarowska F. Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature. Clin Exp Dermatol 2013; 38: 225\u20139.","journal-title":"Clin Exp Dermatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2018.3431\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:23:25Z","timestamp":1741191805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3431"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2018.3431","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"6 Mai 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}